In this report we review evidence that melatonin, a hormone produced b
y the pineal gland during the hours of darkness, plays a major role in
the synchronization of the sleep/wake cycle. The production of melato
nin is regulated by a structure located in the hypothalamus called the
suprachiasmatic nucleus (SCN). The activity of the SCN is strongly af
fected by changes in illumination and, as a consequence, melatonin lev
els are high during darkness and low in the light and it, therefore, r
eflects the cycle. Changes in sleep/wake patterns are among the hallma
rks of biological aging. Complaints of difficulty in initiating and ma
intaining sleep, and daytime drowsiness, are more common in the elderl
y than in any other age group. In this report, we review evidence that
impaired meltonin secretion is associated with sleep disorders in old
age. Circulating melatonin levels have been found to be significantly
lower in elderly insomniacs than ill age-matched controls, and their
onset and peak times delayed. In view of these findings, we investigat
ed the effects of melatonin treatment on melatonin-deficient insomnia
in the elderly. From the results of our study, it seems likely that me
latonin replacement therapy may be beneficial in the initiation and ma
intenance of sleep in this population. Copyright (C) 1997 Elsevier Sci
ence Ireland Ltd.